| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 FSTL5 CANX PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 EHD4 CELSR2 MEGF6 PCDHGB4 NOTCH4 CDHR4 | 4.20e-15 | 749 | 148 | 31 | GO:0005509 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 CDHR4 | 1.87e-26 | 187 | 145 | 26 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 KIFAP3 CELSR2 PCDHGB4 FLRT3 CDHR4 | 4.76e-23 | 313 | 145 | 28 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ITGAE EFR3A KIFAP3 CELSR2 PCDHGB4 DUSP10 FLRT3 IL3 PCK1 NOTCH4 CDHR4 | 8.82e-14 | 1077 | 145 | 34 | GO:0098609 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.90e-06 | 53 | 145 | 6 | GO:0016339 | |
| Domain | Cadherin_CS | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 CDHR4 | 1.51e-31 | 109 | 149 | 26 | IPR020894 |
| Domain | CADHERIN_1 | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 CDHR4 | 4.24e-31 | 113 | 149 | 26 | PS00232 |
| Domain | Cadherin | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 CDHR4 | 4.24e-31 | 113 | 149 | 26 | PF00028 |
| Domain | CADHERIN_2 | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 CDHR4 | 5.46e-31 | 114 | 149 | 26 | PS50268 |
| Domain | - | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 CDHR4 | 5.46e-31 | 114 | 149 | 26 | 2.60.40.60 |
| Domain | CA | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 CDHR4 | 7.02e-31 | 115 | 149 | 26 | SM00112 |
| Domain | Cadherin-like | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 CDHR4 | 8.98e-31 | 116 | 149 | 26 | IPR015919 |
| Domain | Cadherin | FAT4 PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 FAT3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 CDHR4 | 1.46e-30 | 118 | 149 | 26 | IPR002126 |
| Domain | Cadherin_2 | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 9.12e-29 | 65 | 149 | 21 | PF08266 |
| Domain | Cadherin_N | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 9.12e-29 | 65 | 149 | 21 | IPR013164 |
| Domain | Cadherin_tail | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 1.17e-26 | 37 | 149 | 17 | PF15974 |
| Domain | Cadherin_CBD | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 1.17e-26 | 37 | 149 | 17 | IPR031904 |
| Domain | Cadherin_C | PCDHA9 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA7 PCDHGB4 | 3.66e-11 | 42 | 149 | 9 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHA9 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA7 PCDHGB4 | 3.66e-11 | 42 | 149 | 9 | PF16492 |
| Domain | hEGF | 6.86e-05 | 28 | 149 | 4 | PF12661 | |
| Domain | PPTA | 1.89e-04 | 3 | 149 | 2 | PF01239 | |
| Domain | PFTA | 1.89e-04 | 3 | 149 | 2 | PS51147 | |
| Domain | Prenyl_trans_a | 1.89e-04 | 3 | 149 | 2 | IPR002088 | |
| Domain | LRR | 2.13e-04 | 201 | 149 | 8 | PS51450 | |
| Domain | ConA-like_dom | 3.80e-04 | 219 | 149 | 8 | IPR013320 | |
| Domain | Quino_amine_DH_bsu | 6.86e-04 | 22 | 149 | 3 | IPR011044 | |
| Domain | - | 9.84e-04 | 95 | 149 | 5 | 2.60.120.200 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 | 2.76e-35 | 72 | 150 | 22 | 10380929 |
| Pubmed | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 | 1.54e-34 | 77 | 150 | 22 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 | 4.06e-34 | 80 | 150 | 22 | 10716726 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 7.87e-34 | 68 | 150 | 21 | 11230163 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHA9 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 1.41e-33 | 57 | 150 | 20 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHA9 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 2.14e-33 | 58 | 150 | 20 | 30377227 |
| Pubmed | PCDHA9 PCDHGA3 PCDHB5 PCDHB15 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.48e-33 | 24 | 150 | 16 | 24698270 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 6.22e-33 | 74 | 150 | 21 | 10817752 |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | PCDHA9 PCDHGA6 PCDHGA3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 1.83e-31 | 28 | 150 | 16 | 15347688 |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.09e-29 | 15 | 150 | 13 | 15640798 | |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.46e-28 | 17 | 150 | 13 | 29911975 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.82e-28 | 18 | 150 | 13 | 15570159 |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.82e-28 | 18 | 150 | 13 | 10662547 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 | 1.80e-23 | 11 | 150 | 10 | 9655502 |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 IL3 | 1.85e-19 | 75 | 150 | 14 | 15372022 |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 4.83e-17 | 12 | 150 | 8 | 10612399 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | PCDHA9 PCDHGC4 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.66e-16 | 119 | 150 | 14 | 28625976 |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 OAS2 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RANBP17 | 7.09e-15 | 193 | 150 | 15 | 22589738 | |
| Pubmed | PCDHA9 CYTH2 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA3 PCDHA2 PCDHA1 CELSR2 PNMA2 | 1.97e-10 | 329 | 150 | 14 | 17474147 | |
| Pubmed | 1.66e-09 | 5 | 150 | 4 | 34888534 | ||
| Pubmed | Abnormal neocortex arealization and Sotos-like syndrome-associated behavior in Setd2 mutant mice. | 2.03e-09 | 28 | 150 | 6 | 33523829 | |
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 12154121 | ||
| Pubmed | Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease. | 7.86e-08 | 3 | 150 | 3 | 29477871 | |
| Pubmed | Structural Basis of Diverse Homophilic Recognition by Clustered α- and β-Protocadherins. | 7.86e-08 | 3 | 150 | 3 | 27161523 | |
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 2.17e-07 | 59 | 150 | 6 | 23754746 | |
| Pubmed | FAT4 KRT16 NOL6 LRRK2 RNF213 COPG2 PSMD7 RABL3 ADCY9 CEP350 PPP1R15B UGDH PEX5 PRKDC SEC23B | 1.50e-06 | 777 | 150 | 15 | 35844135 | |
| Pubmed | 1.53e-06 | 20 | 150 | 4 | 11322959 | ||
| Pubmed | PCDHA9 HCN1 SLITRK4 PCDHA7 RGS12 ADCY9 EFR3A SLC7A8 KIFAP3 SCN9A FLRT3 | 1.63e-06 | 405 | 150 | 11 | 38187761 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 HCN1 CANX RNF213 PCDHA5 ITGAE TMEM132B OMG DNAH14 RNF123 NOXO1 MEGF6 PRMT5 PRKDC | 4.05e-06 | 736 | 150 | 14 | 29676528 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FNTA RBBP4 PSMD7 PGD EHD4 RNF123 APPL2 PRMT5 RTRAF UGDH NFRKB PNMA2 PEX5 PYGL ANKMY2 PRKDC LSM2 DDX39A SEC23B RABGGTA | 4.83e-06 | 1455 | 150 | 20 | 22863883 |
| Pubmed | KRT16 CANX RNF213 COPG2 PSMD7 SHOC2 ADCY9 TAB3 SPICE1 EHD4 EFR3A CEP350 LONP1 PNMA2 DUSP10 PPP6R2 | 1.31e-05 | 1049 | 150 | 16 | 27880917 | |
| Pubmed | Arrhythmia induced by spatiotemporal overexpression of calreticulin in the heart. | 1.68e-05 | 12 | 150 | 3 | 17482496 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 21526716 | ||
| Pubmed | Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice. | 1.85e-05 | 2 | 150 | 2 | 11086102 | |
| Pubmed | Protein farnesyltransferase and geranylgeranyltransferase share a common alpha subunit. | 1.85e-05 | 2 | 150 | 2 | 2018975 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 2726733 | ||
| Pubmed | TDRD6 mediates early steps of spliceosome maturation in primary spermatocytes. | 1.85e-05 | 2 | 150 | 2 | 28263986 | |
| Pubmed | EHD4 and CDH23 are interacting partners in cochlear hair cells. | 1.85e-05 | 2 | 150 | 2 | 19487694 | |
| Pubmed | Human cardiac myosin heavy chain genes and their linkage in the genome. | 1.85e-05 | 2 | 150 | 2 | 3037493 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 21778428 | ||
| Pubmed | Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6). | 1.85e-05 | 2 | 150 | 2 | 8307559 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 2969919 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 17575272 | ||
| Pubmed | PCDHA9 as a candidate gene for amyotrophic lateral sclerosis. | 1.85e-05 | 2 | 150 | 2 | 38467605 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 9884344 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 12750067 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 23580644 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24829265 | ||
| Pubmed | Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. | 1.85e-05 | 2 | 150 | 2 | 2036722 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25937279 | ||
| Pubmed | Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue. | 1.85e-05 | 2 | 150 | 2 | 15621050 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 18480046 | ||
| Pubmed | Murine pulmonary myocardium: developmental analysis of cardiac gene expression. | 1.85e-05 | 2 | 150 | 2 | 7919499 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26126547 | ||
| Pubmed | Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome. | 1.85e-05 | 2 | 150 | 2 | 26788540 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 34384224 | ||
| Pubmed | Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13. | 1.85e-05 | 2 | 150 | 2 | 2494889 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 36114164 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24224850 | ||
| Pubmed | Intron-less processed Pcdhalpha genes in the central nervous system. | 1.85e-05 | 2 | 150 | 2 | 14697259 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 16088376 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 1776652 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 9541509 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 33973242 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 29489009 | ||
| Pubmed | 2.18e-05 | 13 | 150 | 3 | 12231349 | ||
| Pubmed | 2.50e-05 | 197 | 150 | 7 | 23686814 | ||
| Pubmed | 3.44e-05 | 15 | 150 | 3 | 23515096 | ||
| Pubmed | 3.75e-05 | 210 | 150 | 7 | 16565220 | ||
| Pubmed | 4.23e-05 | 16 | 150 | 3 | 34890862 | ||
| Pubmed | 5.12e-05 | 17 | 150 | 3 | 18279309 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 8620598 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 20923879 | ||
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 5.53e-05 | 3 | 150 | 2 | 1694848 | |
| Pubmed | Two novel CNRs from the CNR gene cluster have molecular features distinct from those of CNR1 to 8. | 5.53e-05 | 3 | 150 | 2 | 11401448 | |
| Pubmed | Discordant on/off switching of gene expression in myocytes during cardiac hypertrophy in vivo. | 5.53e-05 | 3 | 150 | 2 | 18755891 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 29569026 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 11066038 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 21917590 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 18362229 | ||
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 5.53e-05 | 3 | 150 | 2 | 1939265 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 11806752 | ||
| Pubmed | Mutation in myosin heavy chain 6 causes atrial septal defect. | 5.53e-05 | 3 | 150 | 2 | 15735645 | |
| Pubmed | A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. | 5.53e-05 | 3 | 150 | 2 | 15845457 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 22966157 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 33027513 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 6.18e-05 | 398 | 150 | 9 | 35016035 | |
| Pubmed | ZC3H14 RBBP4 ETV5 PSMD7 MED22 RTRAF NFRKB KIAA1958 NCOA1 PYGL PRKDC LSM2 DDX39A DCXR KIF2C | 9.05e-05 | 1103 | 150 | 15 | 34189442 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 9.30e-05 | 420 | 150 | 9 | 28065597 | |
| Pubmed | 9.88e-05 | 21 | 150 | 3 | 25035421 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 17620361 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 32342250 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 9389458 | ||
| Pubmed | hph-1: a mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesis. | 1.10e-04 | 4 | 150 | 2 | 3360305 | |
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 9927321 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 11685209 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 25900833 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 8482409 | ||
| Pubmed | Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. | 1.10e-04 | 4 | 150 | 2 | 11815426 | |
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 28806941 | ||
| Interaction | PCDHA10 interactions | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 8.72e-21 | 22 | 147 | 12 | int:PCDHA10 |
| Interaction | PCDHA7 interactions | 3.13e-12 | 14 | 147 | 7 | int:PCDHA7 | |
| Interaction | PCDHA8 interactions | PCDHA13 PCDHA12 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.91e-12 | 55 | 147 | 10 | int:PCDHA8 |
| Interaction | FLT3 interactions | PCDHA9 PCDHGC4 CANX PCDHA13 PCDHA12 PCDHA11 RNF213 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 LONP1 PRKDC | 1.97e-11 | 318 | 147 | 18 | int:FLT3 |
| Interaction | PCDHA11 interactions | 4.46e-11 | 19 | 147 | 7 | int:PCDHA11 | |
| Interaction | PCDHA9 interactions | 6.00e-11 | 32 | 147 | 8 | int:PCDHA9 | |
| Interaction | PCDHA3 interactions | 1.02e-10 | 34 | 147 | 8 | int:PCDHA3 | |
| Interaction | PCDHA1 interactions | 2.37e-09 | 9 | 147 | 5 | int:PCDHA1 | |
| Interaction | PCDHA4 interactions | 1.23e-08 | 60 | 147 | 8 | int:PCDHA4 | |
| Interaction | RPL23 interactions | FAT4 PCDHGC4 PCDHGA6 FAT3 PCDHB5 LRRK2 PCDHB6 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 ACE2 CELSR2 PRMT5 RLIM PCDHGB4 PCK1 CDHR4 | 1.52e-08 | 540 | 147 | 19 | int:RPL23 |
| Interaction | LONP2 interactions | 1.60e-08 | 62 | 147 | 8 | int:LONP2 | |
| Interaction | PCDHGA10 interactions | 2.07e-07 | 19 | 147 | 5 | int:PCDHGA10 | |
| Interaction | PCDHA6 interactions | 3.33e-07 | 9 | 147 | 4 | int:PCDHA6 | |
| Interaction | PCDHA12 interactions | 1.00e-06 | 46 | 147 | 6 | int:PCDHA12 | |
| Interaction | PCDHA5 interactions | 1.51e-06 | 4 | 147 | 3 | int:PCDHA5 | |
| Interaction | MLYCD interactions | 2.37e-06 | 30 | 147 | 5 | int:MLYCD | |
| Interaction | PCDHA2 interactions | 2.57e-06 | 14 | 147 | 4 | int:PCDHA2 | |
| Interaction | PCDHA13 interactions | 1.30e-05 | 7 | 147 | 3 | int:PCDHA13 | |
| Interaction | SMPD2 interactions | 4.80e-05 | 89 | 147 | 6 | int:SMPD2 | |
| Interaction | LTBP1 interactions | 5.79e-05 | 92 | 147 | 6 | int:LTBP1 | |
| Interaction | POMT1 interactions | 5.95e-05 | 57 | 147 | 5 | int:POMT1 | |
| Interaction | TMEM260 interactions | 1.03e-04 | 13 | 147 | 3 | int:TMEM260 | |
| Cytoband | 5q31 | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 5.94e-31 | 115 | 150 | 21 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 IL3 | 2.12e-23 | 298 | 150 | 22 | chr5q31 |
| GeneFamily | Clustered protocadherins | PCDHA9 PCDHGC4 PCDHGA6 PCDHGA3 PCDHB5 PCDHB15 PCDHB10 PCDHB6 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 9.00e-33 | 64 | 98 | 21 | 20 |
| GeneFamily | Cadherin related | 1.83e-06 | 17 | 98 | 4 | 24 | |
| GeneFamily | Prenyltransferase alpha subunit repeat containing | 8.69e-05 | 3 | 98 | 2 | 687 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 FSTL5 PCDHB5 SLITRK4 PCDHB10 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.83e-13 | 261 | 150 | 17 | MM1277 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 FSTL5 PCDHB5 SLITRK4 PCDHB10 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.00e-13 | 238 | 150 | 16 | M2020 |
| Coexpression | MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED | 1.10e-06 | 93 | 150 | 7 | MM1266 | |
| Coexpression | GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP | 4.48e-06 | 162 | 150 | 8 | M8903 | |
| Coexpression | MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED | 1.02e-05 | 86 | 150 | 6 | M1968 | |
| Coexpression | GSE3982_NKCELL_VS_TH2_DN | 2.08e-05 | 200 | 150 | 8 | M5598 | |
| Coexpression | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 | 2.88e-05 | 103 | 150 | 6 | M1967 | |
| Coexpression | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 | 3.38e-05 | 106 | 150 | 6 | MM1265 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.98e-07 | 192 | 150 | 8 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 158 | 150 | 7 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 158 | 150 | 7 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 158 | 150 | 7 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.16e-06 | 159 | 150 | 7 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.34e-06 | 113 | 150 | 6 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.34e-06 | 113 | 150 | 6 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.34e-06 | 113 | 150 | 6 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.79e-06 | 190 | 150 | 7 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.92e-06 | 191 | 150 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 4.06e-06 | 192 | 150 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 4.06e-06 | 192 | 150 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.20e-06 | 193 | 150 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 4.20e-06 | 193 | 150 | 7 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.20e-06 | 193 | 150 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.35e-06 | 194 | 150 | 7 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.50e-06 | 195 | 150 | 7 | 6867f9c56ea27a17c8c4099aae0d79903c3748a5 | |
| ToppCell | AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.50e-06 | 195 | 150 | 7 | b0cea3f4e59635913d243612f2e8cf4c7b34e726 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.50e-06 | 195 | 150 | 7 | 955a0a7244cd7eaf006a39e1bd03333baf6f30a4 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.65e-06 | 196 | 150 | 7 | a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.81e-06 | 197 | 150 | 7 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.97e-06 | 198 | 150 | 7 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.97e-06 | 198 | 150 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-06 | 199 | 150 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-06 | 199 | 150 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.14e-06 | 199 | 150 | 7 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.31e-06 | 200 | 150 | 7 | 25b573f4427ecafe050ca90bea459f1b25b451cf | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.76e-06 | 132 | 150 | 6 | 6480feb3e4e898d610615ce14f598f419c623e07 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.02e-05 | 85 | 150 | 5 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.02e-05 | 85 | 150 | 5 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 146 | 150 | 6 | 2d907e50206c4762a8baa741363bc7f0a04bd84e | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK_CD56bright|ICU-NoSEP / Disease, Lineage and Cell Type | 2.20e-05 | 167 | 150 | 6 | f4f188a8efca8cdd0ecfb857fe4538c10847eadd | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-05 | 167 | 150 | 6 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 172 | 150 | 6 | feaaf8ca7983d04a59ed0a7b3fb0e6d4b3a055f2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 172 | 150 | 6 | 9adfb4a65669cc536343616637058d0a4728013f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 172 | 150 | 6 | 8aed9c113f27d00401c272a3684495a4bc75bd0f | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.25e-05 | 179 | 150 | 6 | 5787ffba96918db80256ced076a455a84ba01384 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-05 | 180 | 150 | 6 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.56e-05 | 110 | 150 | 5 | 5496c92932195386025254b9129d69b12c8e3340 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.56e-05 | 110 | 150 | 5 | 41306a2d4a5a39569437eb123e47f98ef8afab24 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.56e-05 | 110 | 150 | 5 | 1fe08060248b25329f73b80d74435c108bee1359 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 183 | 150 | 6 | 01e7256c9e0ce53f8e10f3d3a5be15dedd312426 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.67e-05 | 183 | 150 | 6 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.02e-05 | 186 | 150 | 6 | 422d24e3e1a9397bb7d5c7ef75de2fd7ae8e136d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.02e-05 | 186 | 150 | 6 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.02e-05 | 186 | 150 | 6 | 65da0666a10a59f8cc379589860a2e98fe487754 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.02e-05 | 186 | 150 | 6 | dc84fef1ca2f5d5d818b76a3321559e87d1c4a4d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.14e-05 | 187 | 150 | 6 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.14e-05 | 187 | 150 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 188 | 150 | 6 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 188 | 150 | 6 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 4.27e-05 | 188 | 150 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 4.40e-05 | 189 | 150 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | (7)_Epithelial-D_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.53e-05 | 190 | 150 | 6 | 832d6d3ad14665e50623afe1b8586ccae1a97de5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-05 | 191 | 150 | 6 | 6cb2c107bc674aa173b4009f320a1687a76f3979 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 191 | 150 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.66e-05 | 191 | 150 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 4.66e-05 | 191 | 150 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 4.80e-05 | 192 | 150 | 6 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 4.80e-05 | 192 | 150 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.80e-05 | 192 | 150 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 4.80e-05 | 192 | 150 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.80e-05 | 192 | 150 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.94e-05 | 193 | 150 | 6 | 1fdfe08b0c82248545c29b504ac259b093fde29b | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.94e-05 | 193 | 150 | 6 | 5f90e3e526032d82d9dc7e0813fe79ca28dc0719 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-05 | 193 | 150 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.94e-05 | 193 | 150 | 6 | 8187f976fd2d11fad3286690f1a046e894772220 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.08e-05 | 194 | 150 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 5.08e-05 | 194 | 150 | 6 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 195 | 150 | 6 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 5.23e-05 | 195 | 150 | 6 | 33f60762f00cd6f4757d8a8d5227141558ac823e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 195 | 150 | 6 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.23e-05 | 195 | 150 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.34e-05 | 61 | 150 | 4 | 46cdf693c7f2df4fc43df7837b152871af67bef0 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.34e-05 | 61 | 150 | 4 | c73fa489427a6e11badbdfc0324008137806ac7d | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.34e-05 | 61 | 150 | 4 | c2c633f49f6ad8581c33794c909f40aa59f0b5c5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.38e-05 | 196 | 150 | 6 | 82b117be41f2e7d677a42d2a5198726eeccb16d0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.38e-05 | 196 | 150 | 6 | 69f27c2668a9f412b2eb6ca83d11b44863209542 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-05 | 196 | 150 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.38e-05 | 196 | 150 | 6 | 65e161fd672e37a5d10f28011bb422c4d7042d6a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-05 | 197 | 150 | 6 | 0d59a2669de60046e8140d82e67c2b5da4a5683c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-05 | 197 | 150 | 6 | 87c4eafe46f622f9830df75e1ca589e064651db4 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.53e-05 | 197 | 150 | 6 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-05 | 197 | 150 | 6 | 49689a03ab31e53386dbe15c77c09ca3a14ebf4e | |
| ToppCell | AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.69e-05 | 198 | 150 | 6 | 92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-05 | 199 | 150 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-05 | 199 | 150 | 6 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.85e-05 | 199 | 150 | 6 | 5323d49d3be980605b3e609b7f03bddba6e50e8a | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.02e-05 | 200 | 150 | 6 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.02e-05 | 200 | 150 | 6 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-05 | 200 | 150 | 6 | 68b0f987c4fb8078675475f4f1e71302f832ef69 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-05 | 200 | 150 | 6 | 1b527bebbca1ef8c52449e40beb9358e37494e04 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.02e-05 | 200 | 150 | 6 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class | 6.02e-05 | 200 | 150 | 6 | c2df917900872453ea17a39928e39d071a6d3339 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| Drug | Azacitidine | MYH7 PCDHA9 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 MEGF6 KIF2C | 1.00e-07 | 415 | 149 | 15 | ctd:D001374 |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; PC3; HT_HG-U133A | 4.07e-06 | 187 | 149 | 9 | 4581_UP | |
| Disease | 1,5 anhydroglucitol measurement | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.69e-23 | 29 | 142 | 13 | EFO_0008009 |
| Disease | visceral adipose tissue measurement, body mass index | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.20e-16 | 87 | 142 | 13 | EFO_0004340, EFO_0004765 |
| Disease | neutrophil count, basophil count | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 EHD4 NCOA1 | 2.92e-13 | 224 | 142 | 15 | EFO_0004833, EFO_0005090 |
| Disease | post-traumatic stress disorder symptom measurement | 6.23e-09 | 82 | 142 | 8 | EFO_0008535 | |
| Disease | neuroticism measurement, cognitive function measurement | PCDHA9 HCN1 PCDHA13 PCDHA12 PM20D1 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 MED22 | 1.60e-08 | 566 | 142 | 16 | EFO_0007660, EFO_0008354 |
| Disease | Abnormality of refraction | PCDHA9 HCN1 FAT3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SEC23B SLC4A11 | 2.86e-08 | 673 | 142 | 17 | HP_0000539 |
| Disease | neutrophil count | PCDHA9 CANX PCDHA13 CDH23 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 VWA7 EHD4 KIFAP3 MED22 NCOA1 ADGRF5 YY1AP1 PRKDC NOTCH4 | 4.65e-08 | 1382 | 142 | 24 | EFO_0004833 |
| Disease | Sarcosine measurement | 4.24e-06 | 23 | 142 | 4 | EFO_0021668 | |
| Disease | mental development measurement | 6.01e-06 | 25 | 142 | 4 | EFO_0008230 | |
| Disease | post-traumatic stress disorder | 6.43e-06 | 202 | 142 | 8 | EFO_0001358 | |
| Disease | vital capacity | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 B3GNT7 CCNYL1 NCOA1 DUSP10 PPP6R2 | 2.86e-05 | 1236 | 142 | 18 | EFO_0004312 |
| Disease | pulse pressure measurement | MYH6 PCDHA9 FAT3 COBLL1 PCDHA13 PCDHA12 PCDHA11 RNF213 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 AREL1 | 1.30e-04 | 1392 | 142 | 18 | EFO_0005763 |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 1.37e-04 | 4 | 142 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 1.37e-04 | 4 | 142 | 2 | cv:C3495498 | |
| Disease | Caveolinopathy | 1.37e-04 | 4 | 142 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 1.37e-04 | 4 | 142 | 2 | 192600 | |
| Disease | Hypoplastic Left Heart Syndrome | 2.28e-04 | 5 | 142 | 2 | C0152101 | |
| Disease | depressive symptom measurement | PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 NAALADL2 AREL1 MAML3 | 2.31e-04 | 426 | 142 | 9 | EFO_0007006 |
| Disease | cyclic AMP-dependent transcription factor ATF-6 alpha measurement | 3.41e-04 | 6 | 142 | 2 | EFO_0801505 | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 3.41e-04 | 6 | 142 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 3.89e-04 | 71 | 142 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | bipolar disorder, body mass index | 4.10e-04 | 72 | 142 | 4 | EFO_0004340, MONDO_0004985 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 4.75e-04 | 7 | 142 | 2 | C0700053 | |
| Disease | alcohol dependence measurement, electroencephalogram measurement | 4.75e-04 | 7 | 142 | 2 | EFO_0004357, EFO_0007835 | |
| Disease | Obstructive asymmetric septal hypertrophy | 4.75e-04 | 7 | 142 | 2 | C0597124 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 8.10e-04 | 9 | 142 | 2 | C0949658 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 8.10e-04 | 9 | 142 | 2 | C3502809 | |
| Disease | urate measurement, bone density | FSTL5 MINPP1 NAALADL2 DNAH14 SLC7A8 RANBP17 GBP4 PRKDC SLC4A11 NOTCH4 | 8.58e-04 | 619 | 142 | 10 | EFO_0003923, EFO_0004531 |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.01e-03 | 10 | 142 | 2 | cv:C5675009 | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.01e-03 | 10 | 142 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 1.47e-03 | 12 | 142 | 2 | EFO_0801493 | |
| Disease | metabolite measurement, body weight gain | 1.47e-03 | 12 | 142 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | granulins measurement | 1.47e-03 | 12 | 142 | 2 | EFO_0008141 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.47e-03 | 12 | 142 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.47e-03 | 12 | 142 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.73e-03 | 13 | 142 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.32e-03 | 15 | 142 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | P wave duration | 2.32e-03 | 15 | 142 | 2 | EFO_0005094 | |
| Disease | response to lithium ion | 2.51e-03 | 56 | 142 | 3 | GO_0010226 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 2.64e-03 | 57 | 142 | 3 | EFO_0022284 | |
| Disease | Tremor, Rubral | 2.64e-03 | 16 | 142 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.64e-03 | 16 | 142 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 2.64e-03 | 16 | 142 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 2.64e-03 | 16 | 142 | 2 | C0240991 | |
| Disease | Abnormal coordination | 2.64e-03 | 16 | 142 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 2.64e-03 | 16 | 142 | 2 | C0427190 | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 2.98e-03 | 17 | 142 | 2 | DOID:11984 (is_marker_for) | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 3.51e-03 | 63 | 142 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 3.51e-03 | 63 | 142 | 3 | EFO_0022239 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 3.67e-03 | 64 | 142 | 3 | EFO_0022253 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 3.73e-03 | 19 | 142 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | obesity (implicated_via_orthology) | 3.92e-03 | 215 | 142 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 4.17e-03 | 67 | 142 | 3 | EFO_0022245 | |
| Disease | rheumatoid arthritis (is_marker_for) | 4.53e-03 | 69 | 142 | 3 | DOID:7148 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DQFLLDGQLLPDNFI | 226 | P10768 | |
| ENIIDLFNQAAGDAI | 406 | O95394 | |
| NQVALPNIPEFAALD | 2736 | Q96N23 | |
| LLNQQVFNDPLVSEE | 21 | Q9NZD4 | |
| QALNSLLVAELPQFN | 396 | A1IGU5 | |
| ALAQLLVEQNFPAIA | 301 | O00148 | |
| INILDENDNAPRFSQ | 2761 | Q6V0I7 | |
| NNLSNLPQGIFDDLD | 281 | Q9NZU0 | |
| DRNPELQNLLLDDFF | 381 | P52209 | |
| LEILVNDVNDNAPQF | 801 | Q9HCU4 | |
| ILVIDINDNAPEFNS | 336 | Q9H251 | |
| VFVNLLDLNDNDPTF | 876 | Q9H251 | |
| LADDNNLNFLFAPLS | 301 | Q8N7R7 | |
| FLEQAQNITIPENLA | 236 | A6H8M9 | |
| APFAPNLEEINNILE | 836 | Q53SF7 | |
| FAFQNPESIIELNLE | 456 | Q8TCP9 | |
| IALQDSAIINEDNLP | 576 | Q14156 | |
| QFDELNTEILNNLAD | 526 | Q9Y483 | |
| TPIQNDLQEFFALID | 461 | Q9Y620 | |
| PLDDTATVFQQLEQL | 431 | Q9H2T7 | |
| LQVFVLDENDNAPAL | 551 | Q9Y5H5 | |
| VVLDNNDNAPEFLQS | 231 | Q9Y5E4 | |
| DSLPQAVREFLENNA | 21 | P35558 | |
| DQEQFADNQIPLLVI | 131 | Q5HYI8 | |
| LEDQIIQANPALEAF | 216 | P12883 | |
| IDENDNAPEVIFQSL | 336 | Q9UN71 | |
| LQVFVLDENDNAPAL | 551 | Q9Y5H9 | |
| LQVFVLDENDNAPAL | 551 | Q9UN73 | |
| NAFENFQEPDIGLVA | 221 | Q9UHI5 | |
| FIFELIQNADTDQEP | 481 | Q6GTS8 | |
| LQVFVLDENDNAPAL | 551 | Q9UN72 | |
| QVFVLDENDNAPALL | 551 | Q9Y5I1 | |
| IFSVNALDPDVDQNA | 471 | Q9Y5G7 | |
| LQVFVLDENDNAPAL | 551 | Q9Y5H6 | |
| LQVFVLDENDNAPAL | 551 | Q9Y5H8 | |
| IFELQAAVNLALDDQ | 491 | O95256 | |
| LPTLNQEQENFLAVE | 221 | Q6P0N0 | |
| QFPEDSAEQQNELIL | 76 | Q6P4R8 | |
| LANTVPEDDIQDLFN | 316 | Q96JK9 | |
| QLPADEVDTQLLQDA | 71 | Q9Y333 | |
| LIDSSINEPQLQVDF | 26 | A8MUM7 | |
| LILNDFPSVNEAIDQ | 86 | Q15528 | |
| IEAQINNEDLFPTNV | 126 | Q96BX8 | |
| LPFLFLGNEQDAQDL | 326 | Q9Y6W6 | |
| QAQANFFDLENLLDP | 136 | P38570 | |
| VSQQALDLQNLRFDP | 116 | Q9H1B4 | |
| NNFDIDEVQLDPRAL | 371 | Q16659 | |
| ELVAEFLQDQNAPLV | 61 | P50542 | |
| LPNAVLLFEAAVQQD | 351 | P50542 | |
| AAFELNSQLLPQENR | 466 | Q13946 | |
| VNNAAVALLQPFLEV | 81 | Q7Z4W1 | |
| PLFVNLNNELTVEEQ | 916 | Q9H6R4 | |
| IDLNDGNVQDIFALA | 96 | O60662 | |
| AQPILQIDNARLAAD | 186 | P08779 | |
| NNDELEFEQAPEFLL | 1871 | Q5S007 | |
| ALLELLDPEQNANFL | 606 | P36776 | |
| LENAVTALAQLENPA | 326 | Q96PP9 | |
| AEAQDLFRDIQSLPQ | 276 | Q9H223 | |
| DEQFVPDFQSDNLVL | 66 | P41161 | |
| PNQDTEFLERLNLFL | 96 | Q9UL42 | |
| VRLFVLDLNDNAPAV | 551 | Q9Y5F7 | |
| QLLINVLDANDNAPE | 226 | Q9Y5H7 | |
| QVFVLDENDNAPALL | 551 | Q9Y5H7 | |
| VVLDVNDNAPQFAQA | 231 | Q9UN67 | |
| VQILILVLDANDNAP | 226 | Q9Y5E8 | |
| LVLDANDNAPEFVQA | 231 | Q9Y5E8 | |
| EVLAAFNALSLNDNP | 141 | P29728 | |
| EDNIPQLEDVSQFLQ | 221 | P00439 | |
| ADQVAILEAAFLPLQ | 746 | Q3SYG4 | |
| ALEFPHLVVDLADNN | 241 | Q68CR7 | |
| IASVQLPNDDAQFDA | 81 | Q09028 | |
| NIILNNLDLEDINDF | 286 | Q8N475 | |
| TVLDVNDNAPLFDQA | 231 | Q9Y5I3 | |
| LQVFVLDENDNAPAL | 551 | Q9Y5I3 | |
| LQVFVLDENDNAPAL | 551 | Q9Y5I0 | |
| QVFVLDENDNAPALL | 551 | Q9Y5I2 | |
| VSLNLFVLDQNDNAP | 546 | Q9Y5H0 | |
| LQVFVLDENDNAPAL | 551 | Q9UN74 | |
| EDPALQELESNFLIQ | 496 | Q9Y2L6 | |
| FSENNALDLPVEPNE | 421 | Q711Q0 | |
| NELNDPLREEIVNFN | 451 | O60741 | |
| LPLLDFNNLNGEDQD | 51 | P08700 | |
| PDNVEKLLAAADQFN | 106 | Q6JEL2 | |
| QFLVENELLQNTPEE | 81 | Q99418 | |
| QEEIEFLNAIFPNGA | 131 | P17707 | |
| NIQIVDENDNAPVFL | 1756 | Q8TDW7 | |
| ILNPDNSFEILVDQS | 241 | P27824 | |
| EIFEEIFAEDPNLNQ | 2981 | Q5VT06 | |
| PDFQEDNETEINFLL | 426 | Q9BYF1 | |
| LEVLNQIIFIADDPQ | 41 | Q5T1N1 | |
| PINQFSLNFLDQELE | 746 | O60503 | |
| LVPENLLAIFDENEL | 686 | O15033 | |
| LVNENPLLTEEAALN | 181 | Q8IV38 | |
| AFLLPLNQEDNTNLA | 121 | O14744 | |
| QFDIVLPATEFLDQN | 451 | Q8NEU8 | |
| FQEQLAAIPEFLNIG | 611 | Q9UBF2 | |
| PNLNIEQDSFLEDLN | 2071 | Q0VDD8 | |
| LEFLADRQPQENLFV | 251 | Q8NFL0 | |
| PQEVFLQVLNLADDE | 411 | Q16348 | |
| IDFDDVAAINPELLQ | 56 | Q99661 | |
| LDSIENLPFELQRNF | 11 | Q9UNL4 | |
| IPALIELLNAQQEDD | 591 | Q92845 | |
| FADQDDNINAPFDRI | 586 | O75170 | |
| DNINAPFDRIAEINF | 591 | O75170 | |
| LQVFVLDENDNAPAL | 551 | Q9UN75 | |
| VLDINDNVPEFAQEL | 231 | Q9Y5E3 | |
| VLQDELPQLFQDDDV | 476 | O75095 | |
| PEFNNFAAILEQILS | 61 | Q96NL0 | |
| NAEPLINLDVNNPDF | 116 | Q9Y224 | |
| ILNDNLISFLPDNIF | 161 | Q8IW52 | |
| FFIEQNLVAALVNAP | 656 | Q8NBS3 | |
| NEELFNIVDLLTPFQ | 931 | O60522 | |
| NQDNPVIDEIDFLEA | 426 | Q9BVQ7 | |
| AAALDVLQSPQQEAI | 686 | Q14DG7 | |
| NLLNLVDQEERSAAP | 466 | Q8N5C8 | |
| PLQLAQDAIDAFLKQ | 211 | Q1RMZ1 | |
| QDVFNLLPDVSLQEF | 231 | P51665 | |
| NRLPELELEAIDNQF | 866 | Q15788 | |
| ELELVQNAFFTDPND | 211 | Q92696 | |
| DPSQELEFIADILNQ | 181 | P49354 | |
| LTAIEEDPDANNLQI | 976 | Q15858 | |
| LENLEELYLNDNPNL | 516 | Q9UQ13 | |
| LNEPDNPADLEFQQD | 216 | Q8NEZ3 | |
| TLEDQIIQANPALEA | 216 | P13533 | |
| ALDPAAQAFLLEQQL | 166 | Q5SWA1 | |
| DRPFQAQAQESLDVL | 181 | Q8NFA2 | |
| DAQDNREQTPLFLAA | 1761 | Q99466 | |
| IPDQSFDQLFQLQEI | 206 | P23515 | |
| LLQAPLDDAQEILQA | 686 | Q15437 | |
| FNESVIEPQALNDVD | 156 | Q8N0Z3 | |
| AFPTLQAILAQDIQE | 901 | Q8IZF2 | |
| DFQDDLAQLQPLVTA | 31 | E9PGG2 | |
| DDIQALDIFLANLPE | 2991 | Q63HN8 | |
| NLNLQVLSNPEFLAE | 151 | O60701 | |
| PVNIDSQAQLADDVL | 781 | O14924 | |
| EFEERLNFDINLENP | 2446 | Q99973 | |
| AATLQVPVNDLNADL | 266 | Q9UNW1 | |
| VPVNDLNADLIQVAF | 271 | Q9UNW1 | |
| FFALAALVQVNDPDA | 16 | Q6QAJ8 | |
| LNPVEVQAEFLAVAN | 166 | Q8WYR1 | |
| VQELLAPEFAQELQL | 56 | Q96N76 | |
| FQNLPEHLDQLLQVD | 61 | Q5XPI4 | |
| LAQFFLLNEDDDDQP | 531 | Q9NVW2 | |
| SQVLIPEINLNDTFD | 346 | O15344 | |
| EERDFLANNIFPQLN | 36 | Q6P2S7 | |
| LFQQPDLDSALQIAR | 2741 | O95359 | |
| FINALDQLSNPELLF | 3571 | P78527 | |
| FNTPQALRFEELLAN | 101 | Q9H869 | |
| FDVSENPEAIDQLNQ | 156 | Q9ULT6 | |
| SQVLIPDINFNDAFE | 366 | Q9UJV3 | |
| VFDAFPDQVAIQLND | 326 | P06737 | |
| EAALNVTLQLFLEQP | 51 | Q9Y334 | |
| LENLENLDVSAFQAP | 341 | Q92547 | |
| AVDEAALNQALVFLA | 406 | Q5TAA0 | |
| LIDEDLNFVQENPLS | 181 | Q6PJT7 | |
| PEEVLQAEQEFLANA | 211 | Q9UJK0 | |
| ASLLDVLNNEEAQLP | 191 | Q6ICL3 | |
| AEIQVPNLEADLQEL | 56 | Q8WWM1 | |
| LNKFPVFNINDDLND | 396 | Q8N8K9 | |
| VLPFNALDIALEVQN | 646 | Q58DX5 |